Tan Thay
Chief Executive Officer @ Genting Berhad
Kuala Lumpur, Malaysia
Tan Thay is a Series A investor at Genting Berhad in Kuala Lumpur focused on Health Care and Biotechnology. Tan Thay is the Founder & CEO of Genting Malaysia Berhad & he attended University of London.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Tan Thay invests in
Stages Tan Thay invests in
Countries Tan Thay invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (100%)
- Biotechnology 2 (100%)
- Health Diagnostics 2 (100%)
- Genetics 1 (50%)
Stage
- Series A 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California. | $80M / Series A / Mar 04, 2014 | ||
| Applied Proteomics offers a protein biomarker discovery platform to advance the application of proteomics. The company is advancing the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications to power better medical decisions and care. It has developed a proteomics platform solutionto make protein-based biomarker discovery possible as a replicable, industrial application ready to be applied to health diagnostic problems.The company's platform combines improved instrumentation, faster computing, and extensive genome annotations with regimented standard operating procedures, extensive quality controls, and documented processes spanning hundreds of steps from sample collection to processing through informatics. | $28M / Series C / Aug 20, 2013 |
Co-Investors
About Genting Berhad
Genting Berhad is an investment holding and management company with businesses across hospitality, plantations, property development, energy, life sciences, and biotechnology. The company offers resort and entertainment experiences, plantation and downstream products, property projects, power and oil and gas operations, as well as biotechnology and life sciences investments through its group companies.
Genting Berhad Contacts
| Name | Phone | Socials | |
|---|---|---|---|
KONG HAN TAN
Chief Operating Officer
|
|||
|
Tan Thay
Chief Executive Officer
|
|||
|
Goh Lee Sian
Senior Vice President – Legal
|
|||
Kong Han Tan
Chief Operating Officer
|
|||
|
Woon Yoke Sun
Senior Vice President – Strategic Investment
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Tan Thay invest in?
Tan Thay invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tan Thay?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tan Thay last invest?
The most recent investment recorded for Tan Thay closed in Mar 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
